Tokyo, Nov. 17 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000063434) titled 'An exploratory study to investigate the effects of research food intake on skin function' on Nov. 17.

Study Type: Interventional

Study Design: Basic Design - Parallel Randomization - Randomized Blinding - Double blind -all involved are blinded Control - Placebo

Primary Sponsor: Institute - EP-Data Weave Co., Ltd.

Condition: Condition - Healthy adult Classification by malignancy - Others Genomic information - NO

Objective: Narrative objectives1 - To investigate the effects on skin function and safety of continuous intake of the research food for 12 weeks. Basic objectives2 - Efficacy

Intervention: Interventions/Control_1 - The test food is consumed once daily, 3 capsules per day for 12 weeks. Interventions/Control_2 - The control food is consumed once daily, 3 capsules per day for 12 weeks.

Eligibility: Age-lower limit - 30 years-old

Gender - Female Key inclusion criteria - (1) Healthy female aged 30 to under 65 years at the time of informed consent. (2) Subjects who are aware of skin dryness and associated visible changes. (3) Subjects who fully understand the purpose and content of the study and voluntarily provide written informed consent to participate. Key exclusion criteria - (1) Subjects who regularly consume foods rich in lactic acid bacteria or bifidobacteria, or foods/supplements claiming skin or intestinal benefits. (2) Subjects who have undergone cosmetic medical procedures affecting the measurement sites. (3) Subjects who have undergone treatments on the measurement sites within 1 month prior to screening, or plan to do so during the study. (4) Subjects with skin conditions affecting measurements on the measurement sites. (5) Subjects planning severe sunburn from outdoor activities. (6) Subjects who took antibiotics within 1 month, or regularly use drugs affecting bowel habits. (7) Subjects with persistent diarrhea, severe constipation, or chronic gastrointestinal diseases. (8) Subjects with serious diseases or disorders affecting sex hormone secretion. (9) Subjects with potential allergies related to the study. (10) Subjects requiring continuous medication or currently undergoing medical treatment. (11) Current smokers. (12) Excessive alcohol consumers. (13) Shift workers or night-shift workers with irregular lifestyles. (14) Subjects planning overseas travel during the study period. (15) Subjects with clinically significant abnormal laboratory values at screening. (16) Subjects who participated in other clinical trials within 1 month. (17) Pregnant or lactating women, or those planning pregnancy. (18) Subjects judged unsuitable based on the lifestyle questionnaire. (19) Subjects otherwise judged unsuitable by the principal investigator. Target Size - 70

Recruitment Status: Recruitment status - Preinitiation Date of protocol fixation - 2026 Year 10 Month 14 Day Date of IRB - 2026 Year 10 Month 14 Day Anticipated trial start date - 2026 Year 11 Month 18 Day Last follow-up date - 2027 Year 03 Month 16 Day

To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000072604

Disclaimer: Curated by HT Syndication.